Sprout Fund

Sprout Fund is an early-stage venture vehicle whose public footprint suggests a generalist seed strategy, with limited specific data on healthcare focus or AI emphasis from the inputs provided. Funds operating under the Sprout brand have historically backed pre-seed and seed companies across software, consumer, and frontier technology themes, with check sizes typically in the range of one hundred thousand to seven hundred fifty thousand dollars and a syndicate-participant rather than lead orientation. Healthcare AI founders should treat this as a possible source of small early capital rather than a domain expert investor. The natural fit is a pre-seed or seed software company with a generalist appeal, an articulate founder narrative, and a credible team. Founders building therapeutics, regulated devices, or complex healthcare enterprise software are unlikely to find specialist value here. Founders should not expect deep healthcare regulatory or clinical coaching, and the fund will not lead a competitive priced round. The realistic value is small early capital, a check that helps close out a round, and possibly access to a broader generalist network. The best entry path is a warm referral from an existing portfolio founder or a connected angel. Direct outreach via the website or LinkedIn is acceptable but should be tightly framed around what specifically the fund can contribute beyond capital, and founders should set expectations accordingly. Treat this as supplementary capital rather than a lead partner.